Secondary prevention of acute venous thrombosis. Modern trends
Venous thromboembolic complications (VTC) including deep veins thrombosis and pulmonary artery thromboembolia are sufficiently frequent but preventable states. In industrially developed countries 1-2 cases of VTC per 1 thousand persons per year are registered. In USA 900 thousand patients suffer fro...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LTD
2016-12-01
|
| Series: | Амбулаторная хирургия |
| Subjects: | |
| Online Access: | https://www.a-surgeon.ru/jour/article/view/61 |
| _version_ | 1797884007649640448 |
|---|---|
| author | V. Y. Bogachev B. V. Boldin O. V. Dzhenina V. N. Lobanov |
| author_facet | V. Y. Bogachev B. V. Boldin O. V. Dzhenina V. N. Lobanov |
| author_sort | V. Y. Bogachev |
| collection | DOAJ |
| description | Venous thromboembolic complications (VTC) including deep veins thrombosis and pulmonary artery thromboembolia are sufficiently frequent but preventable states. In industrially developed countries 1-2 cases of VTC per 1 thousand persons per year are registered. In USA 900 thousand patients suffer from VTC annually. But these figures are most likely conservative as due to diffuseness of a clinical pattern and insufficient sensitivity of screening tests the frequency of verified VTC doesn't exceed 60-70% [1, 2]. |
| first_indexed | 2024-04-10T04:00:46Z |
| format | Article |
| id | doaj.art-a7ee526a00944031a063ccf40e49610c |
| institution | Directory Open Access Journal |
| issn | 2712-8741 2782-2591 |
| language | Russian |
| last_indexed | 2024-04-10T04:00:46Z |
| publishDate | 2016-12-01 |
| publisher | Remedium Group LTD |
| record_format | Article |
| series | Амбулаторная хирургия |
| spelling | doaj.art-a7ee526a00944031a063ccf40e49610c2023-03-13T07:10:17ZrusRemedium Group LTDАмбулаторная хирургия2712-87412782-25912016-12-0103-4566261Secondary prevention of acute venous thrombosis. Modern trendsV. Y. Bogachev0B. V. Boldin1O. V. Dzhenina2V. N. Lobanov3Российский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссийский национальный исследовательский медицинский университет им. Н.И. ПироговаПервый Флебологический ЦентрПервый Флебологический ЦентрVenous thromboembolic complications (VTC) including deep veins thrombosis and pulmonary artery thromboembolia are sufficiently frequent but preventable states. In industrially developed countries 1-2 cases of VTC per 1 thousand persons per year are registered. In USA 900 thousand patients suffer from VTC annually. But these figures are most likely conservative as due to diffuseness of a clinical pattern and insufficient sensitivity of screening tests the frequency of verified VTC doesn't exceed 60-70% [1, 2].https://www.a-surgeon.ru/jour/article/view/61венозные тромбоэмболические осложненияфакторы рискаантикоагулянтная терапиясулодексидvenous thrombolic complicationsrisk factorsanticoagulant therapysulodexide |
| spellingShingle | V. Y. Bogachev B. V. Boldin O. V. Dzhenina V. N. Lobanov Secondary prevention of acute venous thrombosis. Modern trends Амбулаторная хирургия венозные тромбоэмболические осложнения факторы риска антикоагулянтная терапия сулодексид venous thrombolic complications risk factors anticoagulant therapy sulodexide |
| title | Secondary prevention of acute venous thrombosis. Modern trends |
| title_full | Secondary prevention of acute venous thrombosis. Modern trends |
| title_fullStr | Secondary prevention of acute venous thrombosis. Modern trends |
| title_full_unstemmed | Secondary prevention of acute venous thrombosis. Modern trends |
| title_short | Secondary prevention of acute venous thrombosis. Modern trends |
| title_sort | secondary prevention of acute venous thrombosis modern trends |
| topic | венозные тромбоэмболические осложнения факторы риска антикоагулянтная терапия сулодексид venous thrombolic complications risk factors anticoagulant therapy sulodexide |
| url | https://www.a-surgeon.ru/jour/article/view/61 |
| work_keys_str_mv | AT vybogachev secondarypreventionofacutevenousthrombosismoderntrends AT bvboldin secondarypreventionofacutevenousthrombosismoderntrends AT ovdzhenina secondarypreventionofacutevenousthrombosismoderntrends AT vnlobanov secondarypreventionofacutevenousthrombosismoderntrends |